In silico Identification of Characteristics Spike Glycoprotein of SARS-CoV-2 in the Development Novel Candidates for COVID-19 Infectious Diseases

Código QR

In silico Identification of Characteristics Spike Glycoprotein of SARS-CoV-2 in the Development Novel Candidates for COVID-19 Infectious Diseases

Background: The emergence of infectious diseases caused by SARS-CoV-2 has resulted in more than 90,000 infections and 3,000 deaths. The coronavirus spike glycoprotein encourages the entry of SARS-CoV-2 into cells and is the main target of antivirals. SARS-CoV-2 uses ACE2 to enter cells with an affin...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Taufik Muhammad Fakih, Mentari Luthfika Dewi
Formato:	article
Lenguaje:	EN
Publicado:	Diponegoro University 2020
Materias:	covid-19 sars-cov-2 spike glycoprotein ace-2 in silico study Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9059c8779c104361954a8cc83acbc48a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

In silico investigation of binding affinities between human leukocyte antigen class I molecules and SARS-CoV-2 virus spike and ORF1ab proteins
por: Spyros A. Charonis, et al.
Publicado: (2021)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Guillaume Beaudoin-Bussières, et al.
Publicado: (2020)

T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of Plasmodium malariae share sequence homology
por: Hassan Md. Mehedi, et al.
Publicado: (2021)

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
por: Pavla Taborska, et al.
Publicado: (2021)

Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
por: Balkrishna A, et al.
Publicado: (2021)

Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
por: Damiano Buratto, et al.
Publicado: (2021)

Evolutionary and Antigenic Profiling of the Tendentious D614G Mutation of SARS-CoV-2 in Gujarat, India
por: Jay Nimavat, et al.
Publicado: (2021)

D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage
por: Ya-Wen Cheng, et al.
Publicado: (2021)

Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
por: Christopher A. Beaudoin, et al.
Publicado: (2021)

Inhibition of Coronavirus Entry <italic toggle="yes">In Vitro</italic> and <italic toggle="yes">Ex Vivo</italic> by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain
por: Victor K. Outlaw, et al.
Publicado: (2020)

Potencial Afectación de las Glándulas Salivales en la Infección por SARS-CoV-2 (COVID-19)
por: Melián-Rivas,Andrés, et al.
Publicado: (2021)

Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection
por: Fengling Feng, et al.
Publicado: (2021)

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
por: Chih-Yun Lai, et al.
Publicado: (2021)

Additional Positive Electric Residues in the Crucial Spike Glycoprotein S Regions of the New SARS-CoV-2 Variants
por: Pawłowski PH
Publicado: (2021)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
por: Doris Urlaub, et al.
Publicado: (2021)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Fatima Amanat, et al.
Publicado: (2021)

The Discovery of Tyrosinase Enzyme Inhibitors Activity from Polyphenolic Compounds in Red Grape Seeds through In Silico Study
por: Mentari Luthfika Dewi, et al.
Publicado: (2021)

The Role of the Ocular Tissue in SARS-CoV-2 Transmission
por: Peng M, et al.
Publicado: (2020)

Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract
por: Tuksin Jearanaiwitayakul, et al.
Publicado: (2021)

SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
por: Palaniyandi Velusamy, et al.
Publicado: (2021)

COVID-19: an updated review
por: F. A. Isihak, et al.
Publicado: (2020)

Presencia y Expresión del Receptor ACE2 (Target de SARS-CoV-2) en Tejidos Humanos y Cavidad Oral. Posibles Rutas de Infección en Órganos Orales
por: Pastrian-Soto,Gabriel
Publicado: (2020)

OTRO DESAFIO DE LA NATURALEZA: EL NUEVO CORONAVIRUS VIROLOGÍA Y FISIOPATOLOGÍA DEL SARS-COV-2
por: Gema Pérez A, et al.
Publicado: (2020)

In Silico Modeling as a Perspective in Developing Potential Vaccine Candidates and Therapeutics for COVID-19
por: Reham F. Barghash, et al.
Publicado: (2021)

The importance of smell and taste in everyday life: Dysfunction in COVID-19 patients
por: Stanojlović Olivera
Publicado: (2021)

Evidence of SARS-CoV-2 Transmission Through the Ocular Route
por: Qu JY, et al.
Publicado: (2021)

Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2
por: Matteo Calcagnile, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells
por: Francesca Benedetti, et al.
Publicado: (2021)

A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features
por: Saman Fatihi, et al.
Publicado: (2021)

Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies
por: Ranjan K. Mohapatra, et al.
Publicado: (2021)

Conserved molecular signatures in the spike protein provide evidence indicating the origin of SARS-CoV-2 and a Pangolin-CoV (MP789) by recombination(s) between specific lineages of Sarbecoviruses
por: Bijendra Khadka, et al.
Publicado: (2021)

Measurement of serum ACE status may potentially improve the diagnosis of SARS-CoV-2 infection
por: Gcinokwakhe D Ngcobo
Publicado: (2021)

Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021
por: Reviany V. Nidom, et al.
Publicado: (2021)

Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
por: Enya Qing, et al.
Publicado: (2021)

Compromiso neurológico en infección por COVID-19 en pacientes pediátricos
por: Quiroz S.,Vicente, et al.
Publicado: (2020)

A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD—ACE2 Interaction
por: Narcis Fernandez-Fuentes, et al.
Publicado: (2021)

Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential
por: Slawomir Kubik, et al.
Publicado: (2021)

SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack
por: Evans N, et al.
Publicado: (2021)

Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis
por: Collins DP, et al.
Publicado: (2021)

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
por: Idoia Busnadiego, et al.
Publicado: (2020)